Companies that own Orexo AB
ATP Fondsmaeglerselskab A/S
2,040,633
5.91%
0
0.1%
12/31/2017
Danske Bank A/S (Investment Management Sweden)
559,249
1.62%
-659,320
0.02%
12/31/2016
Danica Pension Livsforsikrings A/S
447,230
1.29%
-52,444
0.66%
12/31/2017
Huber, Reuss & Kollegen Vermögensverwaltung GmbH
270,000
0.78%
270,000
0.8%
06/30/2018
Lancelot Asset Management AB
250,000
0.72%
-536,611
0.37%
12/31/2017
SEB Investment Management AB
249,296
0.72%
26,316
0%
12/31/2017
Lupus alpha Asset Management AG
180,000
0.52%
180,000
0.05%
12/31/2017
SEI Investments Management Corp.
125,121
0.36%
-1
0%
06/30/2018
AcomeA SGR SpA
116,280
0.34%
-220
0.12%
10/31/2017
Lazard Asset Management LLC
107,910
0.31%
0
0%
06/30/2018
| Address |
Rapsgatan 7e
Uppsala UP 751 05
Sweden
|
|
Employees
|
- |
| Website |
http://www.orexo.com |
| Updated |
07/08/2019 |
| Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. Its focuses on the treatment of opioid dependence. Its pipeline comprises of Zubsolv, Abstral, Edluar, Zubsolv, OX51, OX-MP1, and OX382. |
